市場調查報告書
商品編碼
1274202
移動心臟遙測設備全球市場研究報告-2023-2030 年行業分析、規模、份額、增長、趨勢和預測Global Mobile Cardiac Telemetry Device Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
全球對移動心臟遙測設備的需求將從 2022 年的 9.5007 億美元增長到 2030 年的近 24.5669 億美元,預計在 2023-2030 年研究期間將達到 12.6% 的複合年增長率。
移動心臟遙測 (MCT) 設備是一種小型可穿戴設備,可以持續監測患者的心律和其他心臟參數。 它用於診斷和監測引起心悸、頭暈和呼吸急促等症狀的房顫等心律失常。 該設備通常佩戴長達 30 天,在此期間它會記錄患者的心跳和其他心臟數據。 他們也可能有一個內置的事件監視器,允許您記錄患者在監視期間經歷的症狀。 MCT 收集的數據被無線傳輸到監測中心,在那裡可以由訓練有素的專業人員進行分析,以快速識別患者心律的異常情況。
心律失常、心房顫動和心力衰竭等心血管疾病的發病率不斷上升,推動了對移動心臟遙測設備的需求。 據美國心臟協會稱,心血管疾病每年導致超過 1700 萬人死亡。 這證實了MCT設備存在廣闊的市場。 具有實時監測、無線連接和自動分析等功能的新型先進移動心臟遙測設備的開發正在推動市場的增長。 這些設備比傳統的心臟監測方法更方便、更準確,因此受到患者和醫療保健提供者的歡迎。 降低醫療保健成本、改善患者治療效果和提供更方便的護理的需求正在推動遠程患者監護 (RPM) 的快速採用。 移動心臟遙測設備已成為 RPM 的關鍵組成部分,因為它們允許醫療保健專業人員遠程監控患者的心臟健康狀況。 隨著醫療保健提供者尋找為個體患者量身定制護理的方法,對個性化醫療的需求正在增長。 移動心臟遙測設備提供有關患者心臟健康的詳細信息,可用於製定個性化治療計劃。
這份研究報告描述了波特的五力模型、市場吸引力分析和價值鏈分析。 這些工具可幫助您清楚地了解您的行業結構並評估您在全球範圍內的競爭吸引力。 此外,這些工具還能夠全面評估全球移動心臟遙測設備市場的各個細分市場。 移動心臟遙測設備行業的發展和趨勢為這項研究提供了一種整體方法。
本部分提供有關國家和地區細分的詳細數據,以幫助戰略制定者確定各自產品或服務的目標受眾,並將他們與未來的商機聯繫起來。.
本部分涵蓋區域展望,重點介紹北美、歐洲、亞太地區、拉丁美洲、中東和非洲移動心臟遙測設備市場當前和未來的需求。 此外,我們還關注所有主要地區各個應用領域的需求、估計和預測。
這份研究報告還涵蓋了市場主要參與者的綜合概況和全球競爭格局的詳細視圖。 移動心臟遙測設備市場的主要參與者是 BioTelemetry Inc.、ScottCare、Biotricity Inc.、Welch Allyn、Applied Cardiac Systems Inc.、Medicomp Inc.、Preventice Solutions、Telerhythmics LLC、Zoll Medical Corporation、iRhythm Technologies Inc.。本節涵蓋它包括競爭格局的完整圖景,包括各種戰略發展,例如,主要併購、未來能力、合作夥伴關係、財務概覽、合作、新產品開發和新產品發布。
注意:公司簡介中的財務細節和近期發展基於可用信息,可能不包括私營公司。
The global demand for Mobile Cardiac Telemetry Device Market is presumed to reach the market size of nearly USD 2456.69 MN by 2030 from USD 950.07 MN in 2022 with a CAGR of 12.6% under the study period 2023 - 2030.
A Mobile Cardiac Telemetry or MCT device is a small, wearable device that continuously monitors a patient's heart rhythm and other cardiac parameters. It is used to diagnose and monitor cardiac arrhythmias, such as atrial fibrillation, which may cause symptoms such as palpitations, dizziness, and shortness of breath. The device is typically worn for a period of up to 30 days, during which time it records the patient's heart rhythm and other cardiac data. The device may also have a built-in event monitor that allows the patient to record any symptoms they experience during the monitoring period. The data collected by the MCT device is transmitted wirelessly to a monitoring center, where it is analyzed by trained professionals who can quickly identify any abnormalities in the patient's heart rhythm.
The increasing incidence of cardiovascular diseases such as arrhythmias, atrial fibrillation, and heart failure is driving the demand for Mobile Cardiac Telemetry Devices. The American Heart Association states that cardiovascular disease accounts for over 17 million deaths annually. This supports the availability of a wide MCT device market. The development of new and advanced Mobile Cardiac Telemetry Devices with features such as real-time monitoring, wireless connectivity, and automated analysis is driving the growth of the market. These devices are more convenient and accurate than traditional cardiac monitoring methods, making them popular among patients and healthcare providers. The adoption of remote patient monitoring (RPM) is increasing rapidly, driven by the need to reduce healthcare costs, improve patient outcomes, and provide more convenient care. Mobile Cardiac Telemetry Devices are an important part of RPM, as they allow healthcare providers to monitor patients' cardiac health remotely. The demand for personalized medicine is increasing as healthcare providers look for ways to tailor treatments to individual patients. Mobile Cardiac Telemetry Devices provide detailed information about patients' cardiac health, which can be used to develop personalized treatment plans.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mobile cardiac telemetry device. The growth and trends of mobile cardiac telemetry device industry provide a holistic approach to this study.
This section of the mobile cardiac telemetry device market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Mobile Cardiac Telemetry Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the mobile cardiac telemetry device market include BioTelemetry Inc., ScottCare, Biotricity Inc., Welch Allyn, Applied Cardiac Systems Inc., Medicomp Inc., Preventice Solutions, Telerhythmics LLC, Zoll Medical Corporation, iRhythm Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies